Hydrocortisone

Hydrocortisone

Form: Topical Creams/Ointments

Strength: 0.5%, 1%, 2.5%

Reference Brands: Hydrocortone®

Category: Critical Care

Hydrocortisone is a corticosteroid widely used to treat adrenal insufficiency, allergic reactions, inflammation, and shock. It is available in injectable forms (100 mg to 1 g vials), oral tablets (5 mg, 10 mg, 20 mg), and topical preparations (0.5%–2.5%). In the US, Solu-Cortef® and Cortef® by Pfizer are well-known, with generics from Teva, Hikma, and Sandoz. In the EU, brands like Hydrocortone® and Solu-Cortef® dominate alongside generics by Krka and Mylan. Pharma B2B marketplaces ensure seamless sourcing of Hydrocortisone in bulk, supporting hospitals, ICUs, and clinics needing reliable corticosteroid treatment across various administration routes.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.